Overview

Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes Mellitus

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect the investigative drug has on glycemic control in men with type 2 diabetes mellitus (T2DM) and secondary hypogonadism
Phase:
Phase 2
Details
Lead Sponsor:
Repros Therapeutics Inc.
Treatments:
Clomiphene
Enclomiphene
Zuclomiphene